Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 2011 AL 2025

Recent Progress in the Pharmacotherapy of Alzheimer's Disease

Khoury R, Patel K, Gold J, Hinds S, Grossberg GT.

Drugs Aging. 2017 Nov;34(11):811-820. doi: 10.1007/s40266-017-0499-x.

18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)

Martínez G, Vernooij RW, Fuentes Padilla P, Zamora J, Flicker L, Bonfill Cosp X.

Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012884. doi: 10.1002/14651858.CD012884.

Regionally specific changes in the hippocampal circuitry accompany progression of cerebrospinal fluid biomarkers in preclinical Alzheimer's disease

Tardif CL, Devenyi GA, Amaral RSC, Pelleieux S, Poirier J, Rosa-Neto P, Breitner J, Chakravarty MM; PREVENT-AD Research Group.

Hum Brain Mapp. 2018 Feb;39(2):971-984. doi: 10.1002/hbm.23897. Epub 2017 Nov 21.

Alzheimer's disease: evolution of research diagnostic criteria

The Lancet Neurology.

Lancet Neurol. 2017 Dec;16(12):945. doi: 10.1016/S1474-4422(17)30376-9. Epub 2017 Nov 14.

Mild cognitive impairment due to Alzheimer disease: Contemporary approaches to diagnostics and pharmacological intervention

Bachurin SO, Gavrilova SI, Samsonova A, Barreto GE, Aliev G.

Pharmacol Res. 2018 Mar;129:216-226. doi: 10.1016/j.phrs.2017.11.021. Epub 2017 Nov 21.

Polygenic hazard score: an enrichment marker for Alzheimer's associated amyloid and tau deposition

Tan CH, Fan CC, Mormino EC, Sugrue LP, Broce IJ, Hess CP, Dillon WP, Bonham LW, Yokoyama JS, Karch CM, Brewer JB, Rabinovici GD, Miller BL, Schellenberg GD, Kauppi K, Feldman HA, Holland D, McEvoy LK, Hyman BT, Bennett DA, Andreassen OA, Dale AM, Desikan RS; Alzheimer’s Disease Neuroimaging Initiative.

Acta Neuropathol. 2018 Jan;135(1):85-93. doi: 10.1007/s00401-017-1789-4. Epub 2017 Nov 24.

The ROSAS Cohort: A Prospective, Longitudinal Study of Biomarkers for Alzheimer's Disease. Strategy, Methods and Initial Results

de Mauléon A, Soto M, Kiyasova V, Delrieu J, Guignot I, Galtier S, Lilamand M, Cantet C, Lala F, Sastre N, Andrieu S, Pueyo M, Ousset PJ, Vellas B.

J Prev Alzheimers Dis. 2017;4(3):183-193. doi: 10.14283/jpad.2017.8.

Amyloid β oligomers (AβOs) in Alzheimer's disease

Mroczko B, Groblewska M, Litman-Zawadzka A, Kornhuber J, Lewczuk P.

J Neural Transm (Vienna). 2018 Feb;125(2):177-191. doi: 10.1007/s00702-017-1820-x. Epub 2017 Dec 1.

CSF ferritin predicts CSF Aβ decline in biomarker-determined Alzheimer's disease

Connor JR.

J Neurol Neurosurg Psychiatry. 2018 May;89(5):445. doi: 10.1136/jnnp-2017-317050. Epub 2017 Dec 8.

Markers of microglia in post-mortem brain samples from patients with Alzheimer's disease: a systematic review

Hopperton KE, Mohammad D, Trépanier MO, Giuliano V, Bazinet RP.

Mol Psychiatry. 2018 Feb;23(2):177-198. doi: 10.1038/mp.2017.246. Epub 2017 Dec 12.

Effects of stress on emotional memory in patients with Alzheimer's disease and in healthy elderly

Gómez-Gallego M, Gómez-García J.

Int Psychogeriatr. 2018 Aug;30(8):1199-1209. doi: 10.1017/S1041610217002642. Epub 2017 Dec 14.

Amyloid-β and tau complexity - towards improved biomarkers and targeted therapies

Polanco JC, Li C, Bodea LG, Martinez-Marmol R, Meunier FA, Götz J.

Nat Rev Neurol. 2018 Jan;14(1):22-39. doi: 10.1038/nrneurol.2017.162. Epub 2017 Dec 15.

Markers of oxidative damage to lipids, nucleic acids and proteins and antioxidant enzymes activities in Alzheimer's disease brain: A meta-analysis in human pathological specimens

Zabel M, Nackenoff A, Kirsch WM, Harrison FE, Perry G, Schrag M.

Free Radic Biol Med. 2018 Feb 1;115:351-360. doi: 10.1016/j.freeradbiomed.2017.12.016. Epub 2017 Dec 15.

Diagnosing Corticobasal Syndrome Based on the Presence of Visual Hallucinations and Imaging with Amyloid Positron Emission Tomography

Nishida H, Hayashi Y, Harada N, Sakurai T, Wakida K.

Intern Med. 2018 Feb 15;57(4):605-611. doi: 10.2169/internalmedicine.8534-16. Epub 2017 Dec 21.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias